.png)
TL;DRBatch recall (Chargenrückruf) is the measure by which specific affected batches (Chargen) of a medicine are withdrawn from the market and the distribution chain because of a quality or safety defect, as opposed to a full recall of every batch of the product.
A recall (Rückruf) is the corrective action taken when a defect or a new risk makes a medicine unsafe or non-compliant. It reaches back through wholesalers and pharmacies to remove the affected stock from circulation. The word Chargenrückruf narrows that action to the batches actually implicated: a contamination, a mix-up, a labelling or stability fault often sits in one or a few production runs, not in the entire marketed product. Recalling only those batches removes the hazard while leaving unaffected stock available, which matters when the medicine is otherwise in normal supply.
This is a safety and quality act, not a market decision. A company may also stop selling a pack for commercial reasons, but that is a different event with a different legal character. The distinctions below are the part professionals most often need to get right, because the operational response differs at every level.
A recall is initiated by the marketing authorisation holder, the Zulassungsinhaber, or ordered by the competent authority. Most recalls in Germany are voluntary corrective actions the company takes once it identifies a defect, in coordination with the responsible Landesüberwachungsbehörde. The federal higher authorities can also compel one. Under §69 AMG the competent authorities may prohibit the placing on the market of a medicine, order its recall and secure it ("den Rückruf anordnen und diese sicherstellen"), and since a 2019 amendment the BfArM itself can order a recall in urgent cases and issue a public warning. For its own product classes, the Paul-Ehrlich-Institut acts in the same role.
Two federal authorities share competence by product type. The split follows the general allocation in the Arzneimittelgesetz.
| Authority | Product classes | Role in a recall |
|---|---|---|
| BfArM | Most finished medicines (chemically defined and many biologicals) | Assesses quality defects, coordinates recalls across several Länder, can order a recall in urgent cases and warn the public |
| Paul-Ehrlich-Institut (PEI) | Vaccines, blood and plasma products, sera, allergens, advanced therapies | Official batch release and safety monitoring for its classes; assesses and communicates recalls for those products |
| Landesüberwachungsbehörden | All, at pharmacy and wholesale level | Coordinate with the company, set the recall level (wholesale or pharmacy), supervise execution |
Recalls are graded by the health hazard of the defect, following the European Rapid Alert System used across EU inspectorates. The class drives how fast and how far down the chain the recall must reach. The three classes are read as follows.
Alongside a full recall, the AMK also publishes a Chargenüberprüfung, a batch check, where pharmacies are asked to verify whether they hold a named batch before any further step is decided. The classification and the recall level are set in coordination with the responsible state authority.
This is the distinction that most often gets blurred, because all four states can end with a product being unavailable, but only two of them signal a defect. A Chargenrückruf and a full recall are safety acts; a commercial withdrawal and a supply shortage are not.
| Event | Trigger | Scope | Defect involved? |
|---|---|---|---|
| Chargenrückruf | Quality or safety defect in specific batches | The affected Chargen only | Yes |
| Rückruf (full) | Defect or risk affecting the product across batches | All batches of the product | Yes |
| Außer-Vertrieb-Setzung | Commercial decision to stop selling a pack, see Vertriebsstatus | The specific PZN, lasting | No |
| Lieferengpass | Delivery bottleneck, still marketed, see Lieferengpass | Availability of the product | No |
| Versorgungsmangel | Ministerial determination that a shortage threatens care, see Versorgungsmangel | Named medicines, unlocks exemptions | No |
The practical reading: a recall is a reason to pull stock and quarantine it, a withdrawal is a change of trading status, and a shortage is a reason to look for a substitute. Confusing a Chargenrückruf with an Außer-Vertrieb-Setzung, for instance, can mean either over-reacting to a routine delisting or under-reacting to a genuine safety defect.
The federal authorities publish recalls on their own pages, and the Arzneimittelkommission der Deutschen Apotheker (AMK) distributes rapid-alert recall and risk information to pharmacies. The BfArM lists Arzneimittel-Rückrufe and runs the Rapid Alert System, the inter-authority reporting channel under §68 AMG through which quality problems, batch recalls and falsification suspicions are exchanged between EU member states. The AMK feeds "Rückrufe, Chargenrückrufe und Chargenüberprüfungen" to pharmacies through its AMK-Nachrichten, so a pharmacy learns which named batches to pull.
The identifying keys are the batch number (Charge) and the expiry date. A recall notice names the product, the PZN and the specific Chargen with their expiry, and stock is matched against those keys. Because the Falsified Medicines Directive puts the batch number and expiry into the 2D DataMatrix on each pack alongside the serial number, the same batch identifier that carries a pack through verification is the one a recall points to.
pharmazie.com is an aggregator of licensed article data: it carries the distribution status and batch-level context per PZN, which tells a team whether a product is on the market and how it is traded, but the recall determination itself is the act of the authority or the AMK. The platform helps you read the surrounding state of a product and, once a batch is pulled, find an orderable alternative. It is not the official recall register and does not carry the competing standard price service data.
One honest limitation: pharmazie.com surfaces the distribution status and article data around a product, but it is not the source of truth for whether a Chargenrückruf has been issued. That determination lives with the BfArM, the PEI and the AMK, and a specific batch recall with its exact scope and expiry keys should always be checked against the official recall notice.
